Stock 300404 BOJI MEDICAL TECHNOLOGY CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Boji Medical Technology Co.,Ltd.

Equities

300404

CNE100001Y00

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
7.73 CNY +3.07% Intraday chart for Boji Medical Technology Co.,Ltd. +6.33% -13.63%
Apr. 25 Boji Medical Technology Co., Ltd. Announces Profit Distribution Proposal for 2023 CI
Apr. 24 Boji Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,527 2,591 2,513 3,616 2,881 3,419
Enterprise Value (EV) 1 1,430 2,529 2,387 3,243 2,609 3,126
P/E ratio 190 x 397 x 149 x 87.1 x 104 x 136 x
Yield 0.13% 0.07% - 0.14% 0.13% -
Capitalization / Revenue 8.87 x 11.6 x 9.65 x 11.2 x 6.8 x 6.15 x
EV / Revenue 8.31 x 11.3 x 9.16 x 10 x 6.16 x 5.62 x
EV / EBITDA 74 x 130 x 75.6 x 71.1 x 106 x 58.4 x
EV / FCF -63.7 x -51.6 x 39.4 x -51.7 x -24.5 x -105 x
FCF Yield -1.57% -1.94% 2.54% -1.94% -4.08% -0.96%
Price to Book 3.7 x 6.13 x 5.66 x 4.44 x 3.37 x 3.51 x
Nbr of stocks (in thousands) 316,849 315,482 317,267 366,000 368,352 381,990
Reference price 2 4.818 8.214 7.921 9.879 7.820 8.950
Announcement Date 4/26/19 4/23/20 4/26/21 4/25/22 4/25/23 4/24/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 172 224.1 260.5 324.2 423.7 555.8
EBITDA 1 19.32 19.39 31.56 45.62 24.6 53.49
EBIT 1 8.181 5.661 17.06 29.22 6.059 33.02
Operating Margin 4.76% 2.53% 6.55% 9.01% 1.43% 5.94%
Earnings before Tax (EBT) 1 15.38 12.63 27.77 47.09 24.57 17.63
Net income 1 7.4 6.593 16.99 38.88 27.67 24.34
Net margin 4.3% 2.94% 6.52% 11.99% 6.53% 4.38%
EPS 2 0.0254 0.0207 0.0533 0.1134 0.0753 0.0657
Free Cash Flow 1 -22.44 -49.01 60.64 -62.77 -106.4 -29.89
FCF margin -13.05% -21.87% 23.28% -19.36% -25.11% -5.38%
FCF Conversion (EBITDA) - - 192.13% - - -
FCF Conversion (Net income) - - 356.97% - - -
Dividend per Share 2 0.006300 0.005500 - 0.0143 0.0100 -
Announcement Date 4/26/19 4/23/20 4/26/21 4/25/22 4/25/23 4/24/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 97.1 62.4 127 373 272 293
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -22.4 -49 60.6 -62.8 -106 -29.9
ROE (net income / shareholders' equity) 2.69% 2.8% 5.29% 6.53% 3.38% 2.91%
ROA (Net income/ Total Assets) 0.87% 0.57% 1.54% 1.93% 0.32% 1.53%
Assets 1 854.5 1,155 1,102 2,010 8,778 1,588
Book Value Per Share 2 1.300 1.340 1.400 2.220 2.320 2.550
Cash Flow per Share 2 0.1700 0.1800 0.4600 1.050 0.8300 1.060
Capex 1 38 29 31.4 54 118 62.2
Capex / Sales 22.11% 12.94% 12.06% 16.65% 27.79% 11.19%
Announcement Date 4/26/19 4/23/20 4/26/21 4/25/22 4/25/23 4/24/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
BOJI MEDICAL TECHNOLOGY CO.,LTD. Stock Boji Medical Technology Co.,Ltd.
-13.63% 405M
MODERNA, INC. Stock Moderna, Inc.
+25.47% 48.09B
LONZA GROUP AG Stock Lonza Group AG
+46.90% 40.62B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-3.19% 40.43B
CELLTRION, INC. Stock Celltrion, Inc.
-6.20% 28.36B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+9.54% 24.89B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-20.00% 19.01B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+28.83% 12.09B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.86% 11.88B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-1.53% 11.8B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 300404 Stock
  4. Financials Boji Medical Technology Co.,Ltd.